lobbying_activities: 1116881

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1116881	918dea0c-bfcd-4440-9aed-87dd6af1a03a	Q2	BROWN RUDNICK LLP	287895	HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC	2011	second_quarter	PHA	Issues related to supply chain safety and DEA drug; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 - Pill Mill Crackdown Act of 2011; S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011; H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 S. 1002 - Safe Doses Act	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2011-07-18T11:22:23.837000-04:00